C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media

More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)

Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
10/2004
10/21/2004	WO2004081185A3 Methods to enhance the activity of lignocellulose-degrading enzymes
10/21/2004	WO2004061085A3 Methods and apparatus for pathogen detection and analysis
10/21/2004	WO2004050029A3 Novel activated polyethylene glycol compounds
10/21/2004	WO2004042023B1 Stem cell libraries
10/21/2004	WO2003104431A3 Transgenic mammals expressing polyglutamine
10/21/2004	US20040210961 Markerless transformation
10/21/2004	US20040210953 Lysozyme transgenic ungulates
10/21/2004	US20040209801 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; kits
10/21/2004	US20040209797 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells
10/21/2004	US20040209354 Multicompartment apparatus comprising intergratged pneumatic manifold and monolithic elastomer membrane for pumping, isolating, mixing, routing, merging, splitting, preparing and storing volumes of fluid
10/21/2004	US20040209299 In vitro DNA immortalization and whole genome amplification using libraries generated from randomly fragmented DNA
10/21/2004	US20040209290 Prognosing survivability of patients with cell proliferative disorders based on tumor antigen gene expression profile; prognosing tumor recurrence
10/21/2004	CA2809195A1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
10/21/2004	CA2784829A1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
10/21/2004	CA2521469A1 Identification of novel nogo-receptors and methods related thereto
10/21/2004	CA2521438A1 Prion protein binding materials and methods of use
10/21/2004	CA2521402A1 Pectate lyases, nucleic acids encoding them and methods for making and using them
10/21/2004	CA2521217A1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
10/21/2004	CA2488224A1 Irna conjugates
10/20/2004	CN1539022A Viral drug susceptibility testing
10/20/2004	CN1539014A Templated molecules and methods for using such molecules
10/14/2004	WO2004087888A2 Neurotransmitter signaling can regulate life span in c. elegans
10/14/2004	WO2004087887A2 Intracellular complexes as biomarkers
10/14/2004	WO2004087885A2 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
10/14/2004	WO2004087884A2 TARGETING ENZYMES OF THE tRNA SPLICING PATHWAY FOR IDENTIFICATION OF ANTI-FUNGAL AND/OR ANTI-PROLIFERATIVE MOLECULES
10/14/2004	WO2004087883A2 lovE VARIANT REGULATOR MOLECULES
10/14/2004	WO2004087882A2 Neuregulin protein regulation of synaptic proteins
10/14/2004	WO2004087881A2 Process for preparing reverse transcriptase inhibitors
10/14/2004	WO2004087880A2 Compounds and their use to treat diabetes and related disorders
10/14/2004	WO2004087879A2 Pufa polyketide synthase systems and uses thereof
10/14/2004	WO2004087877A2 Selected rna motifs to include cell death and/or apoptosis
10/14/2004	WO2004087876A2 Use of red blood cells to facilitate cell activation
10/14/2004	WO2004087875A2 Nucleic acid-associated proteins
10/14/2004	WO2004087874A2 Novel nucleic acids and polypeptides
10/14/2004	WO2004087873A2 Methods of treating xerostomia and xerophthalmia
10/14/2004	WO2004087871A2 Method of determining gene expression: targeted expressed gene display
10/14/2004	WO2004087868A2 Dna polymerase fusions and uses thereof
10/14/2004	WO2004087865A2 The preparation and application of ligand-biopolymer conjugates
10/14/2004	WO2004087862A2 Tak1-mediated inhibition of osteogenesis
10/14/2004	WO2004087861A2 Biological contamination-removal method
10/14/2004	WO2004072253A9 Human excitatory amino acid transporter-2 gene promoter and uses thereof
10/14/2004	WO2004072232A9 Covalent tethering of functional groups to proteins
10/14/2004	WO2004029196A3 Methods of determining the effect of an agent on diploid cells and/or on the pattern of expression of polypeptides expressed therewith
10/14/2004	WO2003106641A3 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid
10/14/2004	WO2003102132A3 Non-affinity purification of proteins
10/14/2004	WO2003091395A3 Inhibition of immune complex formation
10/14/2004	WO2003035841A3 Methods and systems for dynamic gene expression profiling
10/14/2004	US20040203143 Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
10/14/2004	US20040202662 Humanised antibodies
10/14/2004	CA2521106A1 Intracellular complexes as biomarkers
10/14/2004	CA2520861A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
10/14/2004	CA2520664A1 Targeting enzymes of the trna splicing pathway for identification of anti-fungal and/or anti-proliferative molecules
10/14/2004	CA2520396A1 Pufa polyketide synthase systems and uses thereof
10/14/2004	CA2520181A1 Selected rna motifs to include cell death and/or apoptosis
10/14/2004	CA2519309A1 Dna polymerase fusions and uses thereof
10/13/2004	EP1257584B1 Humanized antibodies that sequester amyloid beta peptide
10/07/2004	WO2004085623A2 A compact synthetic expression vector comprising double-stranded dna molecules and methods of use thereof
10/07/2004	WO2004085622A2 Network-enabled software logic providing discovery and configuration of network appliances coupled to a lan
10/07/2004	WO2004085620A2 Novel attached cell lines
10/07/2004	WO2004085618A2 Method of screening for target ligands
10/07/2004	WO2004085617A2 Timp3 as vegf inhibitor
10/07/2004	WO2004085614A2 Nucleic acid molecules that are differentially regulated in a bipolar disorder and uses thereof
10/07/2004	WO2004085612A2 Metal binding proteins
10/07/2004	WO2004085611A2 Model for mutually exclusive domain folding molecular switch
10/07/2004	WO2004085610A2 Multidimensional mass spectrometry of serum and cellular lipids directly from biologic extracts
10/07/2004	WO2004085609A2 Nanopores, methods for using same, methods for making same and methods for characterizing biomolecules using same
10/07/2004	WO2004085608A2 Methods for high throughput elucidation of transcriptional profiles and genome annotation
10/07/2004	WO2004074427A3 Three dimensional model for protein or part of protein structure
10/07/2004	WO2004072220A3 Process of sex selection of mammal spermatozoa and method to control quality of frozen sexed semen doses
10/07/2004	WO2004069999A3 Screening method
10/07/2004	WO2004067698A3 Helminth-derived antigens having capacity of providing protection against parasites
10/07/2004	WO2004053105A9 Direct snp detection with unamplified dna
10/07/2004	WO2004033640A3 A transgenic animal comprising a gene operably linked to a cell cycle activated promoter
10/07/2004	WO2004016765A9 Method for search based character optimization
10/07/2004	CA2520871A1 Multidimensional mass spectrometry of serum and cellular lipids directly from biologic extracts
10/07/2004	CA2519361A1 Method of screening for target ligands
10/07/2004	CA2517216A1 Nanopores, methods for using same, methods for making same and methods for characterizing biomolecules using same
10/06/2004	EP1464705A1 Optimizing cells for endogenous gene activation
10/06/2004	EP1463805A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
10/06/2004	EP0876498B1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv
10/06/2004	EP0833934B1 Packaging systems for human recombinant adenovirus to be used in gene therapy
10/05/2004	US6800604 Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor
09/2004
09/30/2004	WO2004083405A2 Separation and accumulation of subcellular components, and proteins derived therefrom
09/30/2004	WO2004083402A2 Spleen necrosis predictive genes
09/30/2004	WO2004083401A2 Broken cell wall chlorella and process for preparation thereof
09/30/2004	WO2004083399A2 Aberrantly methylated genes in pancreatic cancer
09/30/2004	WO2004083398A2 Therapeutic uses of hmgn1 and hmgn2
09/30/2004	WO2004083397A2 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv
09/30/2004	WO2004083396A2 Methods for the identification of inhibitors of porphobilinogen deaminase, bifunctional purine biosynthetic protein, and a transcription factor as antibiotics
09/30/2004	WO2004083395A2 Transporters and ion channels
09/30/2004	WO2004083394A2 Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders
09/30/2004	WO2004083393A2 Enhanced protein thermostability and temperature resistance
09/30/2004	WO2004083392A2 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
09/30/2004	WO2004083391A2 Targeted and regional cellular ablation in zebrafish
09/30/2004	WO2004083389A2 Mbcats as modifiers of the beta-catenin pathway and methods of use
09/30/2004	WO2004083388A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
09/30/2004	WO2004083386A2 Methods of making repetitive sequences removed probes and use thereof
09/30/2004	WO2004083385A2 Quorum sensing signaling in bacteria
09/30/2004	WO2004083383A2 Globin variant gene methods and compositions
09/30/2004	WO2004083382A2 Compositions and methods for treating hyperimmune response in the eye

1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 100